STEMCELL Technologies completed the acquisition of Cellular Highways from TTP.

STEMCELL Technologies, a Canadian biotechnology company, completed the acquisition of Cellular Highways, a biotechnology company specializing in advanced cell sorting technologies, from TTP, a technology company. Financial terms were not disclosed. “This acquisition aligns with STEMCELL’s strategic growth in the cell therapy space. With this enhanced ability to support cutting-edge research and biomanufacturing workflows, we will continue to help the scientific community advance research and make discoveries with greater speed and accuracy,” Allen Eaves, STEMCELL President and CEO.